imiquimod has been researched along with glycyrrhizic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Scheinfeld, N | 1 |
| Guo, Q; Han, Y; Tan, G; Tang, Z; Xiong, H; Xu, W; Xu, Y; Zeng, F | 1 |
| Cao, N; Chen, T; Fu, LX; Guo, ZP; Qin, S; Yin, B | 1 |
| Chen, H; Han, L; Ma, Y; Qiong, H; Xu, J; Yan, K; Zhang, N; Zhang, Z | 1 |
| Chen, J; Chen, R; Jin, N; Li, Y; Zhang, B; Zhang, Z | 1 |
| Hang, LY; Li, FQ; Qin, ZJ; Tang, XH; Xue, YY; Yan, Q; Yuan, HL | 1 |
| Jiang, L; Sun, S; Wang, Q; Zhang, Y | 1 |
1 review(s) available for imiquimod and glycyrrhizic acid
| Article | Year |
|---|---|
Update on the treatment of genital warts.
Topics: Abnormalities, Drug-Induced; Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Carcinogenicity Tests; Catechin; Clinical Trials as Topic; Condylomata Acuminata; Dermatologic Agents; Electrocoagulation; Female; Genital Diseases, Female; Genital Diseases, Male; Glycyrrhizic Acid; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hyperthermia, Induced; Imiquimod; Immunotherapy; Incidence; Male; Mice; Mice, Transgenic; Papillomavirus Vaccines; Photochemotherapy; Phytotherapy; Prevalence; Secondary Prevention; United States | 2013 |
6 other study(ies) available for imiquimod and glycyrrhizic acid
| Article | Year |
|---|---|
Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
Topics: Aminoquinolines; Animals; Cell Adhesion; Cell Line; Cell Survival; Female; Glycyrrhizic Acid; Humans; Imiquimod; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Monocytes; NF-kappa B; Phosphorylation; Psoriasis; Signal Transduction; Skin Diseases; Tumor Necrosis Factor-alpha; Up-Regulation | 2015 |
Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model.
Topics: Aminoquinolines; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Glycyrrhizic Acid; HMGB1 Protein; Imiquimod; Phytotherapy; Plant Extracts; Psoriasis | 2017 |
Glycyrrhizin improves the pathogenesis of psoriasis partially through IL-17A and the SIRT1-STAT3 axis.
Topics: Adult; Animals; Anti-Inflammatory Agents; Carbazoles; Disease Models, Animal; Female; Glycyrrhiza; Glycyrrhizic Acid; HaCaT Cells; Humans; Imiquimod; Interleukin-17; Mice; Psoriasis; RNA, Small Interfering; Sirtuin 1; Skin; STAT3 Transcription Factor | 2021 |
Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation.
Topics: Curcumin; Glycyrrhizic Acid; Humans; Imiquimod; Psoriasis; Silicon Dioxide | 2023 |
[Separation, characterization and anti-psoriasis effect of self-assembled nanoparticles from Shaoyao Gancao Decoction].
Topics: Animals; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Glycyrrhizic Acid; Imiquimod; Mice | 2023 |
The therapeutic effect of glycyrrhizic acid compound ointment on imiquimod-induced psoriasis-like disease in mice.
Topics: Animals; Glycyrrhetinic Acid; Glycyrrhizic Acid; Imiquimod; Interleukin-17; Interleukin-23; Mice; Ointments; Psoriasis | 2023 |